Acquired salivary dysfunction - Drugs and radiation

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 132-137

  Fox, Philip C ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; DNA; FUROSEMIDE; HYPNOTIC AGENT; IODINE 131; PILOCARPINE; RADON; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; BEAM THERAPY; CELL DEATH; CLINICAL TRIAL; CONFERENCE PAPER; DNA DAMAGE; EPITHELIUM CELL; GENE EXPRESSION; HEAD CANCER; HUMAN; INTERPHASE; ION TRANSPORT; MITOSIS; MOUTH MUCOSA; NECK CANCER; NONHUMAN; ORAL DRUG ADMINISTRATION; RADIATION DOSE; RADIATION INJURY; SALIVARY GLAND DISEASE; SALIVATION; SIGNAL TRANSDUCTION; TREATMENT PLANNING; XEROSTOMIA;

EID: 0031979913     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09641.x     Document Type: Article

References (26)

1. MANDEL, I.D. 1980. Sialochemistry in diseases and clinical situations affecting the salivary glands. Crit. Rev. Clin. Lab. Sci. 12: 321-366.
2. HANDELMAN, S.L., J.M. BARIC, R.H. SAUNDERS et al. 1989. Hyposalivatory drug use, whole salivary flow, and dryness in older, long-term care residents. Spec. Care Dent. 4: 12-18.
3. SREEBNY, L.M. & A. VALDINI. 1987. Xerostomia: a neglected symptom. Arch. Intern. Med. 147: 1333-1337.
4. SREEBNY, L.M. & S.S. SCHWARTZ. 1986. A reference guide to drugs and dry mouth. Gerodontol. 5: 75-99.
5. Fox, P.C., K.A. BUSCH & B.J. BAUM. 1987. Subjective reports of xerostomia and objective measures of salivary gland performance. J. Am. Dent. Assoc. 115: 581-584.
6. ATKINSON, J.C. & P.C. Fox. 1992. Salivary gland dysfunction. Clin. Ger. Med. 8: 499-511.
7. ATKINSON, J.C., J.B. SHIROKY, A. MACYNSKI & P.C. Fox. 1989. Effects of furosemide on the oral cavity. Gerodontol. 8: 23-26.
8. KOWNIG, B., S. RICAPITO & R. KINNE. 1983. Chloride transport in the thick ascending limb of Henle's loop: potassium dependence and stochiometry of the NaCl cotransport system in plasma membrane vesicles. 'Pfluegers Arch. 399: 173-179.
9. TURNER, R.J. 1993. Mechanisms of fluid secretion by salivary glands. Ann. N.Y. Acad. Sci. 694: 24-35.
10. FRANZEN, L., U. FUNEGARD, T. ERICSON et al 1992. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. Eur. J. Cancer 28: 457-462.
11. MOSSMAN, K.L. 1983. Quantitative radiation dose-response relationships for normal tissues in man. II. Response of the salivary glands during radiotherapy. Radiat. Res. 95: 392-398.
12. VALDEZ, I.H., J.C. ATKINSON, J.A. SHIP et al. 1993. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int. J. Radiat. Oncol. Biol. Phys. 25: 41-47.
13. CREUTZIG, H. 1985. Sialadenitis following iodine-131 therapy for thyroid carcinoma. J. Nucl. Med. 26: 817-818.
14. CONSENSUS DEVELOPMENT PANEL. 1990. Consensus statement: oral complications of cancer therapies. NCI Monogr. 9: 3-8.
15. VALDEZ, I.H. 1991. Radiation-induced salivary dysfunction: clinical course and significance. Spec. Care Dent. 11: 252-255.
16. KASHIMA, H.K., W.R. KIRKHAM & J.R. ANDREWS. 1965. Postradiation sialadenitis. A study of the clinical features, histopathologic changes and serum enzyme variations following irradiation of human salivary glands. Am. J. Roentgenol. Radium Ther Nucl. Med. 94: 271-291.
17. HIRAMATSU, Y., R.M. NAGLER, P.C. Fox &B.J. BAUM. 1994. Rat salivary gland blood How and blood-to-tissue partition coefficients following x-irradiation. Arch. Oral Biol. 39: 77-80.
18. KOHN, W.G., E. GROSSMAN, P.C. Fox et al. 1992. Effect of ionizing radiation on sympathetic nerve function in rat parotid glands. J. Oral Pathol. & Med. 21: 134-137.
19. BODNER, L., B.L. KUYATT, A.R. HAND & B.J. BAUM. 1984. Rat parotid cell function in vitro following X irradiation in vivo. Radiat. Res. 97: 386-395.
20. O'CONNELL, A.C. 1997. Radiation-induced xerostomia in cancer patients: current treatments and future therapies. Genetic modification of surviving cells [abstract]. J. Dent. Res. 76: 251.
21. SHIP, J.A., A. EISDRUCH, E. D'HONDT et al. 1997. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results. J. Dent. Res. 76: 807-813.
22. SODICOFF, M. & A.D. CONGER. 1983. Radioprotection of the rat parotid gland by WR-2721 and isoproterenol and its modification by propanolol. Radiat. Res. 94: 97-104.
23. VALDEZ, I.H., A. WOLFF, J.C. ATKINSON et al. 1993. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 71: 1848-1851.
24. JOHNSON, J.T., G.A. FERRETTI, W.J. NETHERY et al. 1993. Oral pilocarpine for post irradiation xerostomia symptoms and saliva production in patients with head and neck cancer: a multi-center, double-blind, placebo controlled study. N. Engl. J. Med. 329: 390-395.
25. LEVEQUE, F.G., M. MONTGOMERY, D. POTTER et al. 1993. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J. Clin. Oncol. 11: 1124-1131.
26. DELPORTE, C, B.C. O'CONNELL, X. HE et al 1997. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc. Natl. Acad. Sci. USA 94: 3268-3273.